X4 Pharmaceuticals Inc. (XFOR) NASDAQ
$0.98 (0.01) (-0.93%)
Market Cap: $163.94M
As of 05/15/24 04:00 PM EDT. Market closed.
X4 Pharmaceuticals Inc. (XFOR)
NASDAQ
$0.98
(0.01) (-0.93%)
Market Cap: $163.94M
As of 05/15/24 04:00 PM EDT. Market closed.
Add to Portfolio
x4 pharmaceuticals is developing novel therapeutics designed to improve immune cell trafficking and reverse immune suppression, which is fundamental to treating cancer and certain rare, genetic primary immunodeficiency diseases. our oral, small molecule drug candidates inhibit the binding of chemokine cxcl12 to c-x-c receptor type 4 (cxcr4), a receptor-ligand pair that plays an essential role in ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Paula Ragan
Full Time Employees
83
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Paula Ragan
Full Time Employees
83
URL
Address
61 North Beacon Street, 4Th Floor, Massachusetts, Boston, 02134.
PRICE CHART FOR X4 PHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$0.99
Days Range
$0.96 - $1.02
52 week range
$0.57 - $2.58
Volume
1,092,674
Avg. Volume (30 days)
4,447,782
Market Cap
$163.94M
Dividend Yield
-
P/E
-
Shares Outstanding
167,937,781
Open
-
Previous Close
$0.99
Days Range
$0.96 - $1.02
52 week range
$0.57 - $2.58
Volume
1,092,674
Avg. Volume (30 days)
4,447,782
Market Cap
$163.94M
Dividend Yield
-
P/E
-
Shares Outstanding
167,937,781
FINANCIAL STATEMENTS FOR X4 PHARMACEUTICALS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR X4 PHARMACEUTICALS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Taveras Arthur | Chief Scientific Officer | Mar 11, 2024 | Sale | $0.88 | 14,235 | 12,552 | 234,301 | Mar 11, 2024, 05:20 PM |
| Ragan Paula | President and CEO | Mar 11, 2024 | Sale | $0.88 | 49,678 | 43,856 | 765,068 | Mar 11, 2024, 05:20 PM |
| Mostafa Adam S. | Chief Financial Officer | Mar 11, 2024 | Sale | $0.88 | 52,500 | 46,347 | 0 | Mar 11, 2024, 05:19 PM |
| DiBiase Mary | Chief Operating Officer | Mar 11, 2024 | Sale | $0.88 | 15,409 | 13,591 | 291,752 | Mar 11, 2024, 05:19 PM |
| DiBiase Mary | Chief Operating Officer | Feb 12, 2024 | Sale | $1.01 | 3,683 | 3,709 | 307,161 | Feb 12, 2024, 05:23 PM |
| Taveras Arthur | Chief Scientific Officer | Feb 12, 2024 | Sale | $1.01 | 787 | 793 | 248,536 | Feb 12, 2024, 05:23 PM |
| Ragan Paula | President and CEO | Feb 12, 2024 | Sale | $1.01 | 21,695 | 21,892 | 814,746 | Feb 12, 2024, 05:05 PM |
| Mostafa Adam S. | Chief Financial Officer | Feb 12, 2024 | Sale | $1.01 | 27,721 | 27,973 | 52,500 | Feb 12, 2024, 05:03 PM |
| Ragan Paula | President and CEO | Nov 03, 2023 | Sale | $0.90 | 39,906 | 35,915 | 836,441 | Nov 03, 2023, 05:26 PM |
| Ragan Paula | President and CEO | Nov 01, 2023 | Sale | $0.73 | 199,531 | 145,658 | 876,347 | Nov 03, 2023, 05:26 PM |
| Mostafa Adam S. | Chief Financial Officer | Nov 01, 2023 | Sale | $0.73 | 230,645 | 168,371 | 80,221 | Nov 03, 2023, 04:42 PM |
| DiBiase Mary | Chief Operating Officer | Nov 01, 2023 | Sale | $0.73 | 67,695 | 49,417 | 310,844 | Nov 03, 2023, 04:40 PM |
| Baldry Mark | Chief Commercial Officer | Nov 01, 2023 | Sale | $0.73 | 10,257 | 7,488 | 24,690 | Nov 03, 2023, 04:39 PM |
| Taveras Arthur | Chief Scientific Officer | Nov 01, 2023 | Sale | $0.73 | 67,695 | 49,417 | 249,323 | Nov 03, 2023, 04:39 PM |
| DiBiase Mary | Chief Operating Officer | Sep 08, 2023 | Sale | $1.25 | 2,642 | 3,300 | 147,894 | Sep 12, 2023, 04:04 PM |
| WYZGA MICHAEL S | Director | Aug 18, 2023 | Buy | $1.20 | 25,000 | 29,875 | 76,667 | Aug 22, 2023, 04:09 PM |
| Stewart Murray | Interim Chief Medical Officer | Aug 10, 2023 | Sale | $1.06 | 130,056 | 137,859 | 146,504 | Aug 11, 2023, 07:26 PM |
| Mostafa Adam S. | Chief Financial Officer | Jun 30, 2023 | Sale | $1.89 | 2,641 | 4,991 | 80,221 | Jul 05, 2023, 04:04 PM |
| DiBiase Mary | Chief Operating Officer | Jun 23, 2023 | Sale | $1.93 | 857 | 1,654 | 151,000 | Jun 26, 2023, 04:15 PM |
| Mostafa Adam S. | Chief Financial Officer | Jun 23, 2023 | Sale | $1.93 | 5,417 | 10,455 | 82,862 | Jun 26, 2023, 04:13 PM |
| Ragan Paula | President and CEO | Jun 23, 2023 | Sale | $1.92 | 6,724 | 12,910 | 543,797 | Jun 26, 2023, 04:11 PM |
| DiBiase Mary | Chief Operating Officer | Jun 15, 2023 | Sale | $2.23 | 857 | 1,911 | 151,857 | Jun 16, 2023, 04:24 PM |
| Mostafa Adam S. | Chief Financial Officer | Jun 15, 2023 | Sale | $2.22 | 5,417 | 12,026 | 88,279 | Jun 16, 2023, 04:17 PM |
| Ragan Paula | President and CEO | Jun 15, 2023 | Sale | $2.23 | 6,724 | 14,995 | 550,521 | Jun 16, 2023, 04:15 PM |
| Ragan Paula | President and CEO | May 31, 2023 | Sale | $1.95 | 6,292 | 12,269 | 557,245 | May 31, 2023, 05:05 PM |
| DiBiase Mary | Chief Operating Officer | Mar 10, 2023 | Sale | $0.84 | 18,192 | 15,281 | 152,714 | Mar 13, 2023, 04:52 PM |
| Mostafa Adam S. | Chief Financial Officer | Mar 10, 2023 | Sale | $0.84 | 52,500 | 44,100 | 93,696 | Mar 13, 2023, 04:50 PM |
| Taveras Arthur | Chief Scientific Officer | Mar 10, 2023 | Sale | $0.84 | 16,806 | 14,117 | 86,373 | Mar 13, 2023, 04:48 PM |
| Ragan Paula | President and CEO | Mar 10, 2023 | Sale | $0.84 | 49,678 | 41,730 | 563,537 | Mar 13, 2023, 04:46 PM |
| Taveras Arthur | Chief Scientific Officer | Feb 13, 2023 | Sale | $0.93 | 928 | 863 | 103,179 | Feb 15, 2023, 05:13 PM |
| DiBiase Mary | Chief Operating Officer | Feb 13, 2023 | Sale | $0.93 | 4,348 | 4,044 | 170,906 | Feb 15, 2023, 05:13 PM |
| Mostafa Adam S. | Chief Financial Officer | Feb 13, 2023 | Sale | $0.93 | 27,721 | 25,781 | 146,196 | Feb 15, 2023, 05:12 PM |
| Ragan Paula | President and CEO | Feb 13, 2023 | Sale | $0.93 | 21,695 | 20,176 | 613,215 | Feb 15, 2023, 05:11 PM |
| Ragan Paula | President and CEO | Jun 03, 2022 | Sale | $1.21 | 6,292 | 7,613 | 661,806 | Jun 06, 2022, 04:14 PM |
| Mostafa Adam S. | Chief Financial Officer | Aug 17, 2021 | Sale | $5.10 | 10,832 | 55,243 | 120,945 | Aug 19, 2021, 04:26 PM |
| Meisner Derek M | General Counsel | Aug 17, 2021 | Sale | $5.10 | 8,332 | 42,493 | 72,730 | Aug 19, 2021, 04:26 PM |
| Ragan Paula | President and CEO | Aug 17, 2021 | Sale | $5.10 | 13,448 | 68,585 | 469,004 | Aug 19, 2021, 04:26 PM |
| Ragan Paula | President and CEO | Jul 15, 2021 | Sale | $5.78 | 13,448 | 77,729 | 482,452 | Jul 16, 2021, 04:01 PM |
| Mostafa Adam S. | Chief Financial Officer | Jun 30, 2021 | Sale | $6.64 | 2,641 | 17,536 | 131,777 | Jul 01, 2021, 08:18 AM |
| Mostafa Adam S. | Chief Financial Officer | Jun 24, 2021 | Sale | $7.01 | 5,417 | 37,973 | 134,418 | Jun 25, 2021, 04:03 PM |
| Meisner Derek M | General Counsel | Jun 24, 2021 | Sale | $7.00 | 4,166 | 29,162 | 81,062 | Jun 25, 2021, 04:03 PM |
| Ragan Paula | President and CEO | Jun 02, 2021 | Sale | $9.50 | 2,400 | 22,800 | 406,248 | Jun 02, 2021, 04:51 PM |
| Ragan Paula | President and CEO | Apr 05, 2021 | Sale | $9.17 | 2,400 | 22,008 | 415,152 | Apr 07, 2021, 09:20 AM |
| Ragan Paula | President and CEO | Mar 02, 2021 | Sale | $9.74 | 2,400 | 23,376 | 272,923 | Mar 02, 2021, 07:05 PM |
| Ragan Paula | President and CEO | Feb 02, 2021 | Sale | $7.88 | 2,400 | 18,912 | 275,323 | Feb 03, 2021, 05:10 PM |
| Ragan Paula | President and CEO | Jan 05, 2021 | Sale | $7.00 | 2,400 | 16,800 | 277,723 | Jan 06, 2021, 08:25 AM |
| Ragan Paula | President and CEO | Dec 23, 2020 | Sale | $7.00 | 4,800 | 33,600 | 280,123 | Dec 28, 2020, 04:27 PM |
| Ragan Paula | President and CEO | Oct 05, 2020 | Sale | $7.00 | 1,797 | 12,579 | 284,923 | Oct 06, 2020, 08:53 AM |
| Ragan Paula | President and CEO | Oct 02, 2020 | Sale | $7.00 | 603 | 4,221 | 286,720 | Oct 05, 2020, 04:38 PM |
| Mostafa Adam S. | Chief Financial Officer | Sep 21, 2020 | Sale | $7.08 | 10,834 | 76,705 | 29,589 | Sep 22, 2020, 04:11 PM |
| Skerlj Renato | Chief Scientific Officer | Sep 09, 2020 | Sale | $8.05 | 5,834 | 46,964 | 42,076 | Sep 10, 2020, 08:36 AM |
| Ragan Paula | President and CEO | Sep 09, 2020 | Sale | $8.04 | 8,840 | 71,074 | 287,323 | Sep 10, 2020, 08:35 AM |
| Meisner Derek M | General Counsel | Sep 09, 2020 | Sale | $8.05 | 8,334 | 67,089 | 16,666 | Sep 10, 2020, 08:31 AM |
| Ragan Paula | President and CEO | Sep 02, 2020 | Sale | $7.99 | 2,400 | 19,176 | 296,163 | Sep 03, 2020, 05:15 PM |
| Ragan Paula | President and CEO | Aug 03, 2020 | Sale | $7.45 | 2,400 | 17,880 | 208,912 | Aug 04, 2020, 04:33 PM |
| Ragan Paula | President and CEO | Jul 02, 2020 | Sale | $9.05 | 2,400 | 21,720 | 211,312 | Jul 06, 2020, 04:24 PM |
| Mostafa Adam S. | See Remarks | Jun 30, 2020 | Option Exercise | $9.32 | 916 | 8,537 | 7,923 | Jul 01, 2020, 04:10 PM |
| Mostafa Adam S. | See Remarks | Jun 30, 2020 | Sale | $9.04 | 1,725 | 15,594 | 8,839 | Jul 01, 2020, 04:10 PM |
| Ragan Paula | President and CEO | Jun 03, 2020 | Sale | $8.88 | 9,707 | 86,198 | 213,712 | Jun 03, 2020, 04:46 PM |
| Ragan Paula | President and CEO | Jun 02, 2020 | Sale | $8.65 | 2,400 | 20,760 | 223,419 | Jun 03, 2020, 04:46 PM |
| Ragan Paula | President and CEO | Jun 01, 2020 | Sale | $8.63 | 4,275 | 36,893 | 225,819 | Jun 03, 2020, 04:46 PM |
| Ragan Paula | President and CEO | May 04, 2020 | Sale | $8.92 | 2,400 | 21,408 | 230,094 | May 05, 2020, 05:25 PM |
| Ragan Paula | President and CEO | Apr 02, 2020 | Sale | $8.40 | 2,400 | 20,160 | 232,494 | Apr 03, 2020, 12:00 AM |
| Ragan Paula | President and CEO | Mar 02, 2020 | Sale | $10.64 | 2,400 | 25,536 | 234,894 | Mar 03, 2020, 12:00 AM |
| EMBL Technology Fund II GmbH & Co. KG | 10% Owner | Nov 20, 2017 | Buy | $10.00 | 20,000 | 200,000 | 370,454 | Nov 20, 2017, 09:56 PM |
| NeoMed Innovation V L.P. | 10% Owner | Nov 20, 2017 | Buy | $10.00 | 300,000 | 3,000,000 | 867,639 | Nov 20, 2017, 06:15 PM |
| Nessi Claudio | Director | Nov 20, 2017 | Buy | $10.00 | 300,000 | 3,000,000 | 867,639 | Nov 20, 2017, 05:43 PM |
| SVLSF V, LLC | 10% Owner | Nov 20, 2017 | Buy | $10.00 | 500,000 | 5,000,000 | 1,868,961 | Nov 20, 2017, 05:37 PM |
| MCGUIRE TERRANCE | Director | Nov 20, 2017 | Buy | $10.00 | 17,533 | 175,330 | 35,146 | Nov 20, 2017, 05:36 PM |
| MCGUIRE TERRANCE | Director | Nov 20, 2017 | Buy | $10.00 | 482,467 | 4,824,670 | 1,803,429 | Nov 20, 2017, 05:36 PM |
| Gerngross Tillman U. | Director | Nov 20, 2017 | Buy | $10.00 | 200,000 | 2,000,000 | 392,821 | Nov 20, 2017, 05:32 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Nov 20, 2017 | Option Exercise | $10.00 | 500,000 | 5,000,000 | 1,868,966 | Nov 20, 2017, 05:32 PM |
| GORDON CARL L | Director | Nov 20, 2017 | Buy | $10.00 | 500,000 | 5,000,000 | 1,868,966 | Nov 20, 2017, 05:31 PM |
| Polaris Venture Management Co. V, L.L.C. | 10% Owner | Nov 20, 2017 | Buy | $10.00 | 17,533 | 175,330 | 35,146 | Nov 20, 2017, 05:28 PM |
| Polaris Venture Management Co. V, L.L.C. | 10% Owner | Nov 20, 2017 | Buy | $10.00 | 482,467 | 4,824,670 | 1,803,429 | Nov 20, 2017, 05:28 PM |
| Ross Michael Jay | Director | Nov 20, 2017 | Buy | $10.00 | 500,000 | 5,000,000 | 1,868,961 | Nov 20, 2017, 05:28 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Taveras Arthur | Chief Scientific Officer | 03/11/2024 | 12,552 |
| Ragan Paula | President and CEO | 03/11/2024 | 43,856 |
| Mostafa Adam S. | Chief Financial Officer | 03/11/2024 | 46,347 |
| DiBiase Mary | Chief Operating Officer | 03/11/2024 | 13,591 |
| DiBiase Mary | Chief Operating Officer | 02/12/2024 | 3,709 |
| Taveras Arthur | Chief Scientific Officer | 02/12/2024 | 793 |
| Ragan Paula | President and CEO | 02/12/2024 | 21,892 |
| Mostafa Adam S. | Chief Financial Officer | 02/12/2024 | 27,973 |
| Ragan Paula | President and CEO | 11/03/2023 | 35,915 |
| Ragan Paula | President and CEO | 11/01/2023 | 145,658 |
| Mostafa Adam S. | Chief Financial Officer | 11/01/2023 | 168,371 |
| DiBiase Mary | Chief Operating Officer | 11/01/2023 | 49,417 |
| Baldry Mark | Chief Commercial Officer | 11/01/2023 | 7,488 |
| Taveras Arthur | Chief Scientific Officer | 11/01/2023 | 49,417 |
| DiBiase Mary | Chief Operating Officer | 09/08/2023 | 3,300 |
| WYZGA MICHAEL S | Director | 08/18/2023 | 29,875 |
| Stewart Murray | Interim Chief Medical Officer | 08/10/2023 | 137,859 |
| Mostafa Adam S. | Chief Financial Officer | 06/30/2023 | 4,991 |
| DiBiase Mary | Chief Operating Officer | 06/23/2023 | 1,654 |
| Mostafa Adam S. | Chief Financial Officer | 06/23/2023 | 10,455 |
| Ragan Paula | President and CEO | 06/23/2023 | 12,910 |
| DiBiase Mary | Chief Operating Officer | 06/15/2023 | 1,911 |
| Mostafa Adam S. | Chief Financial Officer | 06/15/2023 | 12,026 |
| Ragan Paula | President and CEO | 06/15/2023 | 14,995 |
| Ragan Paula | President and CEO | 05/31/2023 | 12,269 |
| DiBiase Mary | Chief Operating Officer | 03/10/2023 | 15,281 |
| Mostafa Adam S. | Chief Financial Officer | 03/10/2023 | 44,100 |
| Taveras Arthur | Chief Scientific Officer | 03/10/2023 | 14,117 |
| Ragan Paula | President and CEO | 03/10/2023 | 41,730 |
| Taveras Arthur | Chief Scientific Officer | 02/13/2023 | 863 |
| DiBiase Mary | Chief Operating Officer | 02/13/2023 | 4,044 |
| Mostafa Adam S. | Chief Financial Officer | 02/13/2023 | 25,781 |
| Ragan Paula | President and CEO | 02/13/2023 | 20,176 |
| Ragan Paula | President and CEO | 06/03/2022 | 7,613 |
| Mostafa Adam S. | Chief Financial Officer | 08/17/2021 | 55,243 |
| Meisner Derek M | General Counsel | 08/17/2021 | 42,493 |
| Ragan Paula | President and CEO | 08/17/2021 | 68,585 |
| Ragan Paula | President and CEO | 07/15/2021 | 77,729 |
| Mostafa Adam S. | Chief Financial Officer | 06/30/2021 | 17,536 |
| Mostafa Adam S. | Chief Financial Officer | 06/24/2021 | 37,973 |
| Meisner Derek M | General Counsel | 06/24/2021 | 29,162 |
| Ragan Paula | President and CEO | 06/02/2021 | 22,800 |
| Ragan Paula | President and CEO | 04/05/2021 | 22,008 |
| Ragan Paula | President and CEO | 03/02/2021 | 23,376 |
| Ragan Paula | President and CEO | 02/02/2021 | 18,912 |
| Ragan Paula | President and CEO | 01/05/2021 | 16,800 |
| Ragan Paula | President and CEO | 12/23/2020 | 33,600 |
| Ragan Paula | President and CEO | 10/05/2020 | 12,579 |
| Ragan Paula | President and CEO | 10/02/2020 | 4,221 |
| Mostafa Adam S. | Chief Financial Officer | 09/21/2020 | 76,705 |
| Skerlj Renato | Chief Scientific Officer | 09/09/2020 | 46,964 |
| Ragan Paula | President and CEO | 09/09/2020 | 71,074 |
| Meisner Derek M | General Counsel | 09/09/2020 | 67,089 |
| Ragan Paula | President and CEO | 09/02/2020 | 19,176 |
| Ragan Paula | President and CEO | 08/03/2020 | 17,880 |
| Ragan Paula | President and CEO | 07/02/2020 | 21,720 |
| Mostafa Adam S. | See Remarks | 06/30/2020 | 8,537 |
| Mostafa Adam S. | See Remarks | 06/30/2020 | 15,594 |
| Ragan Paula | President and CEO | 06/03/2020 | 86,198 |
| Ragan Paula | President and CEO | 06/02/2020 | 20,760 |
| Ragan Paula | President and CEO | 06/01/2020 | 36,893 |
| Ragan Paula | President and CEO | 05/04/2020 | 21,408 |
| Ragan Paula | President and CEO | 04/02/2020 | 20,160 |
| Ragan Paula | President and CEO | 03/02/2020 | 25,536 |
| EMBL Technology Fund II GmbH & Co. KG | 10% Owner | 11/20/2017 | 200,000 |
| NeoMed Innovation V L.P. | 10% Owner | 11/20/2017 | 3,000,000 |
| Nessi Claudio | Director | 11/20/2017 | 3,000,000 |
| SVLSF V, LLC | 10% Owner | 11/20/2017 | 5,000,000 |
| MCGUIRE TERRANCE | Director | 11/20/2017 | 175,330 |
| MCGUIRE TERRANCE | Director | 11/20/2017 | 4,824,670 |
| Gerngross Tillman U. | Director | 11/20/2017 | 2,000,000 |
| ORBIMED ADVISORS LLC | 10% Owner | 11/20/2017 | 5,000,000 |
| GORDON CARL L | Director | 11/20/2017 | 5,000,000 |
| Polaris Venture Management Co. V, L.L.C. | 10% Owner | 11/20/2017 | 175,330 |
| Polaris Venture Management Co. V, L.L.C. | 10% Owner | 11/20/2017 | 4,824,670 |
| Ross Michael Jay | Director | 11/20/2017 | 5,000,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN X4 PHARMACEUTICALS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 8,735,867 | 0.00028% | 3.78% | Other |
| ORBIMED ADVISORS LLC | 7,133,515 | 0.18% | No change | Other |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,276,315 | 0.01% | No change | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 2,945,424 | 0.00038% | 5.1% | Other |
| OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,335,521 | 0.13% | -23.38% | Value |
| ROYCE & ASSOCIATES LP | 342,363 | 0.00425% | -11.84% | Value |
| AQR CAPITAL MANAGEMENT LLC | 35,927 | 0.00009% | -78.14% | Other |
CHANGE IN SHARES OUTSTANDING FOR X4 PHARMACEUTICALS INC
STOCK BUYBACKS FOR X4 PHARMACEUTICALS INC
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
1.02%
1Q
06/30/2023
17.93%
2Q
03/31/2023
36.33%
3Q
BUYBACK ANNOUNCEMENT(S) FOR X4 PHARMACEUTICALS INC
LOADING...